IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hudson Executive Capital LP

Q3 2017 Holdings

Filed 2017-11-14 | 6 holdings | $41.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atricure Inc(ATRC)COM04963C209$41.5M1,855,00099.6%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$57.9K971,0000.1%
CIT Group Inc(CITUSD)COM NEW125581801$52.5K1,070,8570.1%
Acorda Therapeutics IncCOM00484M106$21.1K893,5000.1%
Corindus Vascular Robotics I(CVRSEUR)COM218730109$17.2K11,336,1540.0%
Magellan Health IncCOM NEW559079207$8.5K98,7000.0%